Chemical Projects
Description
Orlistat CAS 96829-58-2
Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity. It is marketed as a prescription drug under the trade name Xenical by Roche in most countries, and is sold over-the-counter as Alli by GlaxoSmithKline in the United Kingdom and the United States.Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended
Benefits aside, however, orlistat is notorious for its gastrointestinal side effects (sometimes referred to as treatment effects), which can include steatorrhea (oily, loose stools). They decrease with time, however, and are the most frequently reported adverse effects of the drug.In the United States and the European Union, orlistat is available for sale without a prescription. Over-the-counter approval was controversial in the United States, with consumer advocacy group Public Citizen repeatedly opposing it on safety and efficacy grounds.[10] Generic formulations of orlistat are available in some countries. In Australia it is listed as an S3 medication and so is available over the counter in pharmacies.
At times, such as in spring 2012, orlistat has come into short supply, with consequent price increases because of nonavailability of one of the drug& acute;s components.
Read More
Shanghai RoughChem Co.,Ltd
DNP,2,4-Dinitrophenol,Sibutramine HCL,Phentermine HCL,Orlistat,Lorcaserin,Naltrexone
Address: No2541,Jinxiu Road,Pudong District,
shanghai, shanghai
China, 20000
Tel: 0086-21-51677888
Fax: 0086-21-51677888
